167 related articles for article (PubMed ID: 20622350)
1. An imported enteric fever caused by a quinolone-resistant Salmonella Typhi.
Somily AM
Ann Saudi Med; 2010; 30(4):313-6. PubMed ID: 20622350
[TBL] [Abstract][Full Text] [Related]
2. Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon.
Nkemngu NJ; Asonganyi ED; Njunda AL
BMC Infect Dis; 2005 Jun; 5():49. PubMed ID: 15969764
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi.
Kadhiravan T; Wig N; Kapil A; Kabra SK; Renuka K; Misra A
BMC Infect Dis; 2005 May; 5():37. PubMed ID: 15904505
[TBL] [Abstract][Full Text] [Related]
4. High level of resistance to nalidixic acid in Salmonella enterica serovar Typhi in Central India.
Kumar Y; Sharma A; Mani KR
J Infect Dev Ctries; 2009 Jul; 3(6):467-9. PubMed ID: 19762961
[TBL] [Abstract][Full Text] [Related]
5. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
[TBL] [Abstract][Full Text] [Related]
6. Validation of Pefloxacin for detection of fluoroquinolone (FQ) resistance among
Inayath SB; Broor S; Gupta R; Agarwal P; Majumder S; Anveshi AK; Gaind R
J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34356003
[No Abstract] [Full Text] [Related]
7. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH
Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin-resistant Salmonella causing enteric fever.
Capoor MR; Rawat D; Nair D; Hasan AS; Deb M; Aggarwal P; Pillai P
J Med Microbiol; 2007 Nov; 56(Pt 11):1490-1494. PubMed ID: 17965350
[TBL] [Abstract][Full Text] [Related]
9. [A case of Salmonella enterica serovar typhi with decreased susceptibility to ciprofloxacin].
Gaborieau V; Weill FX; Marchou B
Med Mal Infect; 2010 Dec; 40(12):691-5. PubMed ID: 20724089
[TBL] [Abstract][Full Text] [Related]
10. Lower Susceptibility to Fluoroquinolones and a gyrA Gene Mutation in Salmonella Typhi Isolates from Enteric Fever Patients.
Shrestha SK; Khadka S; Rayamajhee B; Thapa A; Sharma S; Shrestha B; Poudel P
J Nepal Health Res Counc; 2022 Nov; 20(2):517-523. PubMed ID: 36550738
[TBL] [Abstract][Full Text] [Related]
11. Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serovar typhi and paratyphi A.
Manchanda V; Bhalla P; Sethi M; Sharma VK
Indian J Med Microbiol; 2006 Apr; 24(2):101-6. PubMed ID: 16687859
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility patterns of Salmonella enterica serotype typhi in eastern Nepal.
Khanal B; Sharma SK; Bhattacharya SK; Bhattarai NR; Deb M; Kanungo R
J Health Popul Nutr; 2007 Mar; 25(1):82-7. PubMed ID: 17615907
[TBL] [Abstract][Full Text] [Related]
13. Enteric fever caused by Salmonella isolates with decreased susceptibility to ciprofloxacin.
Karunanayake L; Atukorala SD
Ceylon Med J; 2004 Dec; 49(4):137-8. PubMed ID: 15693457
[TBL] [Abstract][Full Text] [Related]
14. Typhoid fever due to multiresistant Salmonella enterica serovar typhi having reduced susceptibility to ciprofloxacin and nalidixic acid resistance.
Panhotra BR; Saxena AK; Al-Ghamdi AM
Saudi Med J; 2004 Oct; 25(10):1509-11. PubMed ID: 15494840
[No Abstract] [Full Text] [Related]
15. Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study.
Crump JA; Kretsinger K; Gay K; Hoekstra RM; Vugia DJ; Hurd S; Segler SD; Megginson M; Luedeman LJ; Shiferaw B; Hanna SS; Joyce KW; Mintz ED; Angulo FJ;
Antimicrob Agents Chemother; 2008 Apr; 52(4):1278-84. PubMed ID: 18212096
[TBL] [Abstract][Full Text] [Related]
16. Trends in antimicrobial susceptibility of Salmonella Typhi from North India (2001-2012).
Singhal L; Gupta PK; Kale P; Gautam V; Ray P
Indian J Med Microbiol; 2014; 32(2):149-52. PubMed ID: 24713900
[TBL] [Abstract][Full Text] [Related]
17. Rationale of azithromycin prescribing practices for enteric fever in India.
Rai S; Jain S; Prasad KN; Ghoshal U; Dhole TN
Indian J Med Microbiol; 2012; 30(1):30-3. PubMed ID: 22361757
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India.
Bandyopadhyay R; Balaji V; Yadav B; Jasmine S; Sathyendra S; Rupali P
Trop Doct; 2018 Jul; 48(3):182-188. PubMed ID: 29495943
[TBL] [Abstract][Full Text] [Related]
19. Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin--an emerging problem in Bangladesh.
Rahman MM; Haq JA; Morshed MA; Rahman MA
Int J Antimicrob Agents; 2005 Apr; 25(4):345-6. PubMed ID: 15784317
[No Abstract] [Full Text] [Related]
20. Emergence of nalidixic acid-resistant Salmonella enterica serovar Typhi resistant to ciprofloxacin in India.
Kownhar H; Shankar EM; Rajan R; Rao UA
J Med Microbiol; 2007 Jan; 56(Pt 1):136-137. PubMed ID: 17172529
[No Abstract] [Full Text] [Related]
[Next] [New Search]
